{"id":"https://openalex.org/W319509224","doi":null,"title":"A potent erythropoietin mimic human antibody interacts through a novel binding site Running titile: EPOR AB ACTIVATES THROUGH A NOVEL BINDING SITE","display_name":"A potent erythropoietin mimic human antibody interacts through a novel binding site Running titile: EPOR AB ACTIVATES THROUGH A NOVEL BINDING SITE","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W319509224","mag":"319509224"},"language":"en","primary_location":{"id":"mag:319509224","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/David_Egan5/publication/242634745_A_potent_erythropoietin_mimic_human_antibody_interacts_through_a_novel_binding_site_Running_titile_EPOR_AB_ACTIVATES_THROUGH_A_NOVEL_BINDING_SITE/links/54f5c0b00cf2ca5efefd2025.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"David A. Egan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Egan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017860424","display_name":"John E. Harlan","orcid":"https://orcid.org/0000-0003-0948-7823","observed_orcids":["https://orcid.org/0000-0003-0948-7823"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John E. Harlan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0948-7823","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053056085","display_name":"Richard R. Lesniewski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard R. Lesniewski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054105958","display_name":"Edward B. Reilly","orcid":"https://orcid.org/0000-0003-1999-7501","observed_orcids":["https://orcid.org/0000-0003-1999-7501"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward B. Reilly","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1999-7501","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100394554","display_name":"Zhihong Liu","orcid":"https://orcid.org/0000-0001-6093-0726","observed_orcids":["https://orcid.org/0000-0001-6093-0726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhihong Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6093-0726","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038597530","display_name":"Vincent S. Stoll","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent S. Stoll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026627782","display_name":"Peter J. DeVries","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. DeVries","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049985536","display_name":"Clarissa G. Jakob","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clarissa G. Jakob","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010161697","display_name":"Nancy Xie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nancy Xie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020275047","display_name":"Robert L. Simmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L. Simmer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014891900","display_name":"E Walther Susan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Walther Susan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108193027","display_name":"Susan E. Lacy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan E. Lacy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erythropoietin-receptor","display_name":"erythropoietin receptor","score":0.9710000157356262},{"id":"https://openalex.org/keywords/agonistic-antibodies","display_name":"agonistic antibodies","score":0.8960000276565552},{"id":"https://openalex.org/keywords/receptor-activation-mechanism","display_name":"receptor activation mechanism","score":0.7829999923706055},{"id":"https://openalex.org/keywords/antigen-binding-site","display_name":"antibody binding sites","score":0.609000027179718},{"id":"https://openalex.org/keywords/receptor-conformational-change","display_name":"receptor conformational change","score":0.7549999952316284},{"id":"https://openalex.org/keywords/erythropoiesis","display_name":"erythropoiesis","score":0.7110000252723694},{"id":"https://openalex.org/keywords/anemia-treatment","display_name":"anemia treatment","score":0.6819999814033508},{"id":"https://openalex.org/keywords/transgenic-mouse-model","display_name":"transgenic mouse model","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C31102739","wikidata":"https://www.wikidata.org/wiki/Q14904899","display_name":"Erythropoietin receptor","level":3,"score":0.9663063287734985},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.8896788358688354},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6485010981559753},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5203344821929932},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.4203068017959595},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.4137970805168152},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4083004891872406},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.40256184339523315},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36236435174942017},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3298148512840271},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24708256125450134},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.24654218554496765},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18649667501449585},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11371174454689026}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:319509224","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/David_Egan5/publication/242634745_A_potent_erythropoietin_mimic_human_antibody_interacts_through_a_novel_binding_site_Running_titile_EPOR_AB_ACTIVATES_THROUGH_A_NOVEL_BINDING_SITE/links/54f5c0b00cf2ca5efefd2025.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W71611872","https://openalex.org/W569951484","https://openalex.org/W1503711258","https://openalex.org/W1539796472","https://openalex.org/W1542140512","https://openalex.org/W1594700207","https://openalex.org/W1866293307","https://openalex.org/W1965405264","https://openalex.org/W1985997318","https://openalex.org/W1990789777","https://openalex.org/W1991607336","https://openalex.org/W1994286350","https://openalex.org/W1995017064","https://openalex.org/W1999590520","https://openalex.org/W2005002385","https://openalex.org/W2007680976","https://openalex.org/W2012264968","https://openalex.org/W2015758016","https://openalex.org/W2016665838","https://openalex.org/W2045153667","https://openalex.org/W2053725913","https://openalex.org/W2061776631","https://openalex.org/W2070921472","https://openalex.org/W2071457756","https://openalex.org/W2078390838","https://openalex.org/W2086937859","https://openalex.org/W2088157674","https://openalex.org/W2097493124","https://openalex.org/W2103530688","https://openalex.org/W2108511043","https://openalex.org/W2111184408","https://openalex.org/W2116661176","https://openalex.org/W2123255556","https://openalex.org/W2125890769","https://openalex.org/W2129711592","https://openalex.org/W2131930650","https://openalex.org/W2141487347","https://openalex.org/W2145908121","https://openalex.org/W2154434149","https://openalex.org/W2155772167","https://openalex.org/W2161523038","https://openalex.org/W2169177790","https://openalex.org/W2238093709","https://openalex.org/W2419282883"],"related_works":["https://openalex.org/W1985562310","https://openalex.org/W2059677018","https://openalex.org/W2140440388","https://openalex.org/W591002951","https://openalex.org/W1993135569","https://openalex.org/W7099234634","https://openalex.org/W7095576602","https://openalex.org/W631362204","https://openalex.org/W2155479284","https://openalex.org/W1989055017"],"abstract_inverted_index":{"Recombinant":[0],"human":[1,124],"erythropoietin":[2,12],"(rHu-EPO)":[3],"is":[4,166],"used":[5],"to":[6,20,91,130,152],"treat":[7],"anemia":[8],"by":[9,203],"activating":[10],"the":[11,68,142,146,153,196],"receptor":[13,173],"(EPOR)":[14],"in":[15,122],"erythroid":[16],"progenitor":[17],"cells":[18],"leading":[19],"proliferation":[21],"and":[22,79,93,116],"differentiation":[23],"into":[24],"mature":[25],"red":[26,72],"blood":[27],"cells.":[28],"To":[29],"allow":[30],"less":[31,117,137],"frequent":[32,138],"dosing,":[33,62],"a":[34,43,102,123,162,169,177,186,192],"hyperglycosylated":[35],"version":[36],"of":[37,70,77,82,120,133,141,145,172,195],"EPO":[38,65,92],"has":[39],"been":[40],"developed":[41],"with":[42,168],"longer":[44,57],"half-life.":[45],"In":[46],"principle,":[47],"an":[48,55],"agonistic":[49,106],"antibody":[50,85,107],"targeting":[51,109],"EPOR":[52,110,125,147],"would":[53],"offer":[54],"even":[56],"half-life,":[58],"support":[59],"robust":[60],"monthly":[61],"and,":[63],"unlike":[64],"products,":[66],"reduce":[67],"risk":[69],"pure":[71],"cell":[73],"aplasia.":[74],"The":[75],"efficiency":[76],"signaling":[78],"corresponding":[80],"potency":[81],"previously":[83],"reported":[84],"mimics":[86],"are":[87],"generally":[88],"suboptimal":[89],"compared":[90,129],"not":[94],"suitable":[95],"for":[96],"clinical":[97],"use.":[98],"Here":[99],"we":[100],"describe":[101],"potent,":[103,113],"fully":[104],"human,":[105],"(ABT007)":[108],"that":[111,165,185],"supports":[112],"more":[114],"sustained,":[115],"pulsatile":[118],"elevation":[119],"hematocrit":[121],"expressing-transgenic":[126],"mouse":[127],"model":[128],"standard":[131],"doses":[132],"rHu-EPO":[134],"while":[135],"requiring":[136],"dosing.":[139],"Resolution":[140],"crystal":[143],"structure":[144],"extracellular":[148],"domain":[149],"(ECD)":[150],"complexed":[151],"ABT007":[154],"Fab":[155],"fragment,":[156],"determined":[157],"at":[158],"3.2":[159],"A,":[160],"identifies":[161],"binding":[163],"site":[164],"consistent":[167],"novel":[170],"mechanism":[171],"activation":[174],"based":[175],"on":[176,205],"unique,":[178],"antibody-imposed,":[179],"conformational":[180],"change.":[181],"These":[182],"results":[183],"demonstrate":[184],"symmetric":[187],"molecule":[188],"can":[189],"serve":[190],"as":[191],"potent":[193],"activator":[194],"EPOR.":[197],"2":[198],"For":[199],"personal":[200],"use":[201],"only.":[202],"guest":[204],"June":[206],"2,":[207],"2013.":[208],"bloodjournal.hematologylibrary.org":[209],"From":[210]},"counts_by_year":[],"updated_date":"2026-10-11T09:32:39.932853","created_date":"2016-06-24T00:00:00"}